Clinical Trial Update: Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating venetoclax in combination with azacitidine as initial therapy for newly diagnosed T-cell acute lymphoblastic leukemia, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: T-cell Acute Lymphoblastic Leukemia, Recruiting | Phase 2 | Status: RECRUITING